https://biotechmorning.com/news/esperion-goes-private-archimed-deal Biotech Morning en 2026-05-03T14:07:20.953Z Why Esperion Just Ghosted Wall Street https://biotechmorning.com/news/gilead-walks-away-arcus-oncology-alliance Biotech Morning en 2026-05-03T14:06:46.063Z Gilead Just Walked Away From a $1 Billion Bet on Cancer https://biotechmorning.com/news/merck-billion-dollar-google-cloud-ai-deal-2 Biotech Morning en 2026-05-03T14:06:02.149Z Merck Just Bet $1 Billion That Google Can Fix Drug Discovery https://biotechmorning.com/news/fomat-topography-health-largest-embedded-research-organization Biotech Morning en 2026-05-02T14:12:07.194Z The Biggest Clinical Trial Land Grab You Didn't See Coming https://biotechmorning.com/news/hemab-ipo-doubled-day-one-blood-disease-bet Biotech Morning en 2026-05-02T14:11:31.267Z Hemab's IPO Doubled on Day One. The Blood Disease Bet Wall Street Couldn't Resist. https://biotechmorning.com/news/seaport-therapeutics-ipo-neuropsychiatry-bet Biotech Morning en 2026-05-02T14:10:50.297Z The Brain Drug Startup That Convinced Wall Street to Bet $255M on Crazy https://biotechmorning.com/news/viking-obesity-drug-ligand-legal-dispute Biotech Morning en 2026-05-02T14:10:12.836Z Viking's Obesity Blockbuster Just Got a Legal Problem https://biotechmorning.com/news/summit-therapeutics-ivonescimab-trial-miss Biotech Morning en 2026-05-02T14:09:35.778Z Summit Therapeutics Was Supposed to Dethrone Keytruda. Then the Data Arrived. https://biotechmorning.com/news/fda-cber-prasad-exits-again Biotech Morning en 2026-05-02T14:08:54.198Z The FDA's Biologics Gatekeeper Just Walked Out (Again) https://biotechmorning.com/news/first-protac-fda-approval-vepdegestrant-breast-cancer Biotech Morning en 2026-05-02T14:08:14.162Z The First Drug That Eats a Cancer Protein Just Got FDA Approval https://biotechmorning.com/news/genomics-greywolf-autoimmune-gene-targets Biotech Morning en 2026-05-02T14:07:34.291Z Two Oxford Companies Think Your Genes Hold the Key to Autoimmune Disease https://biotechmorning.com/news/fda-slams-door-cheap-liraglutide-compounding Biotech Morning en 2026-05-02T14:06:55.767Z The FDA Just Slammed the Door on Cheap Liraglutide